PrimeraDx said this week that Fayyaz Memon has been appointed as vice president of regulatory affairs and quality assurance.
Memon has held management positions with Thermo Fisher Scientific, Digene, Johnson & Johnson, and SmithKline Beecham, PrimeraDx said. He earned his MBA in operation and quality management and MS in mechanical engineering from Drexel University.
In July, PrimeraDx said that it would begin selling its multiplex PCR-based molecular testing technology as an open platform to laboratories wishing to develop their own molecular tests (PCR Insider, 7/14/11).
PrimeraDx is also readying its own molecular diagnostic test, a multiplex assay for Clostridium difficile, for submission to the US Food and Drug Administration.
Memon joins the company "at a key time, as we've recently launched our first product based on our unique technology for multiplex quantitative PCR, and we will be going to the FDA for clearance later this year," President and CEO Matthew McManus said in a statement.